Autor: |
Jiménez, Natalia, Garcia de Herreros, Marta, Reig, Òscar, Marín-Aguilera, Mercedes, Aversa, Caterina, Ferrer-Mileo, Laura, García-Esteve, Samuel, Rodríguez-Carunchio, Leonardo, Trias, Isabel, Font, Albert, Rodriguez-Vida, Alejo, Ángel Climent, Miguel, Cros, Sara, Chirivella, Isabel, Domènech, Montserrat, Figols, Mariona, Carles, Joan, Suárez, Cristina, Herrero Rivera, Daniel, González-Billalabeitia, Enrique, Cívico, Claudia, Sala-González, Núria, Ruiz de Porras, Vicenç, Ribal, Maria J., Prat, Aleix, Mellado, Begoña |
Zdroj: |
European Urology Oncology; 20240101, Issue: Preprints |
Abstrakt: |
Low mRNA expression of two or more of the tumor suppressor genes (TSGs) RB1, PTEN, and TP53correlated with adverse outcomes in patients with metastatic hormone-sensitive prostate cancer. These results were validated independently in the CHAARTED trial dataset. No interaction was observed between TSG signature and treatment. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|